Patient info Open main menu

LAMISIL TABLETS 250 MG - patient leaflet, side effects, dosage

Dostupné balení:

Patient leaflet - LAMISIL TABLETS 250 MG

3. how to take lamisil tablets

The doctor will decide what dose of Lamisil Tablets you should take. Always take the tablets exactly as your doctor has told you to. The dose will be on the pharmacist’s label. Check the label carefully. It should tell you how many tablets to take, and how often. If you are not sure, ask your doctor or pharmacist. Keep taking the tablets for as long as you have been told unless you have any problems. In that case, check with your doctor.

The usual dose for adults, including the elderly, is 250 mg once a day.

  • For skin infections continue taking the tablets for 2 to 6 weeks.
  • For nail infections treatment usually lasts for between 6 weeks and 3 months, although some patients with toenail infections may need to be treated for 6 months or longer.
  • If your kidneys are not working very well, your doctor may reduce the dose of Lamisil Tablets you take.
  • Swallow the tablets whole with a glass of water.

What if you forget to take a dose?

If you miss taking a Lamisil Tablet, do not worry. Take it as soon as you remember. Take your next tablet at the usual time, then carry on as normal until you have finished all the tablets. It is important that you finish all the tablets you have been given unless your doctor tells you to stop taking them.

What if you take too many tablets?

All tablets can be risky if you take too many. If you take too many Lamisil Tablets at once, tell your doctor or hospital casualty department as soon as possible. Take your medicine pack with you so that people can see what you have taken.

4. possible side effects

Lamisil Tablets are suitable for most people, but, like all medicines, they can sometimes cause side effects. Any side effects are usually mild or moderate and don’t last for too long.

Some side effects can be serious

Stop taking the tablets and tell your doctor immediately if you notice any of the following rare symptoms:

  • Yellowing of your skin or eyes. Unusually dark urine or pale faeces, unexplained persistent nausea, stomach problems, loss of appetite or unusual tiredness or weakness (this may indicate liver problems), increase in liver enzymes which may be noted on a blood test result
  • Severe skin reactions including rash, light sensitivity, blistering or wheals
  • Weakness, unusual bleeding, bruising, abnormal pale skin, unusual tiredness, or weakness or breathlessness on exertion or frequent infections (this may be a sign of blood disorders)
  • Difficulty breathing, dizziness, swelling mainly of the face and throat, flushing, crampy abdominal pain, stiffness, rash, fever or swollen/ enlarged lymph nodes (possible signs of severe allergic reactions)
  • Symptoms such as rash, fever, itching, tiredness or if you notice appearance of purplish spots under the skin surface (signs of blood vessel inflammation)
  • Severe upper stomach pain which spreads to the back (possible signs of pancreas inflammation)
  • Unexplained muscle weakness or pain, or dark (red-brown) urine (possible signs of muscle breakdown)

The most common side effects are:-

  • Headache
  • Stomach problems such as loss of appetite, ache, indigestion, feeling bloated or sick
  • Diarrhoea
  • Itching, rash or swelling
  • Pains in the muscles and joints

The side effects listed below have also been reported.

Up to 1 in 100 people have experienced:

Taste loss and taste disturbance. This usually disappears within several weeks after you stop taking the medicine. However, a very small number of people, (less than 1 in 10,000), have reported that the taste disturbance lasts for some time and, as a result, they go off their food and lose weight. There have also been reports of some people experiencing anxiety or symptoms of depression as a result of these taste disturbances.

Up to 1 in 1,000 people have experienced:

  • Feeling unwell, dizzy
  • Numbness or tingling

Up to 1 in 10,000 people have experienced:

  • Feeling tired
  • Decrease in the number of some blood cells. You may notice that you seem to bleed or bruise more easily than normal, or you may catch infections easily and these might be more severe than usual
  • Psoriasis like skin eruptions, or worsening of any psoriasis including a rash or eruption of small pus containing blisters
  • Vertigo
  • Hair loss
  • Onset or worsening of a condition called lupus (a long-term illness with symptoms including skin rash and pain in the muscles and joints)

5. how to store lamisil tablets

Store the tablets in their original pack away from direct light. Store below 25°C.

Keep all medicines out of the reach and sight of children.

Do not take the tablets after their expiry date which is printed on the outside of the pack.

If your doctor tells you to stop taking Lamisil

Tablets, please take any unused tablets back to your pharmacist to be destroyed. Only keep the tablets if the doctor tells you to. Do not throw them away with your normal household water or waste. This will help to protect the environment.

6. contents of the pack and other information

What Lamisil Tablets contain

– Each tablet contains 250 mg of the active ingredient terbinafine.

– The other excipients are magnesium stearate, colloidal anhydrous silica, hydroxypropyl­methylcellulo­se, sodium carboxymethyl starch and microcrystalline cellulose.

What Lamisil Tablets look like and contents of the pack

Lamisil Tablets are round, whitish or very pale yellow tablets marked with a score line on one side and ‘LAMISIL 250’ on the other.

They come in blister packs of 7, 14 or 28 tablets. Not all pack sizes are marketed.

Marketing Authorisation Holder

Novartis Pharmaceuticals UK Limited,

2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane,

London, W12 7FQ

United Kingdom.

Manufacturer

Novartis Pharmaceuticals UK Limited,

2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane,

London, W12 7FQ

United Kingdom.

Lek d.d., PE PROIZVODNJA LENDAVA

Trimlini 2D

Lendava, 9220

Slovenia.

This leaflet was last revised in September 2020.

If you would like any more information, or would like the leaflet in a different format, please contact Medical Information at Novartis Pharmaceuticals UK Ltd, telephone number 01276 698370.

LAMISIL is a registered trade mark

Copyright Novartis Pharmaceuticals UK Limited

1883436 GB